After The Winter: Life Sciences New Era of Capital & Conviction
After the Winter: Life Science's New Era of Capital & Conviction
Join Savills, Nucleate NY, and NY Bio for an evening of focused conversation on life science capital and conviction in 2026.
We're bringing together some of the sharpest investors, industry experts, and senior executives in life science to talk openly about what's driving capital decisions right now. We will be covering topics that are reshaping the industry: rebounding deal volumes, FDA uncertainty, the surge in China licensing, shifting exit dynamics, and what it really takes to raise in this market.
Whether you're a founder trying to understand what VCs actually want to see, or an investor navigating a rapidly shifting market, we'd love to have you in the room. Spots are limited, and attendance is curated — request your invite below.
Schedule:
5:30 – 6:15 PM - Welcome Reception & Introductions
6:15 – 6:45 PM - First Checks, Big Bets: Backing Biotech from Zero
6:45 – 7:15 PM - Momentum or Mirage: The Market Outlook
7:15 – 8:00 PM - Networking
Meet the Organizers:
Savills is a global real estate advisory firm with deep expertise in the life sciences sector. With a dedicated life sciences practice spanning lab and office strategy, market research, and occupancy planning, Savills helps founders and growing companies navigate the intersection of capital, space, and science — from seed-stage incubators to large-scale R&D campuses. Visit www.savills.us for more information.
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information.
NewYorkBIO is the leading advocate for New York's life science community and the state's officially designated affiliate to the national Biotechnology Industry Organization. Bringing together hundreds of New York's bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercializing treatments and cures for patients, NewYorkBIO connects the ecosystem through policy, programming, and community. Visit www.newyorkbio.org for more information.